152 results on '"Falge, Christiane"'
Search Results
2. Chapter 9 The Cultural Resilience in Nuer Conversion and a ‘Capitalist Missionary’
3. Gesundheitliche Verhältnisse verändern durch Community Forschung im Bochumer Stadtteillabor
4. Kollaboratives Forschen und Wissen für die Öffentlichkeit: Gesellschaftliche Interventionen der Medizinethnologie
5. Migrating bodies in the context of health and racialisation in Germany
6. Defining therapy goals for major molecular remission in chronic myeloid leukemia: results of the randomized CML Study IV
7. Diversitäts- und kultursensible Gesundheitsinformationen für mehr digitale Gesundheitskompetenz: Eine kollaborative Community-Forschung zu Barrieren und Bedarfen
8. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
9. The Effects Of Nuer Transnational Churches On The Homeland Communities
10. Migrants and Health
11. Countering Rupture: Young Nuer in New Religious Movements
12. Orientierungshilfen zum Umgang mit Gesundheitsinformationen im Internet: Diversitätssensible Stärkung digitaler Gesundheitskompetenz
13. Explaining survival differences between two consecutive studies with allogeneic stem cell transplantation in patients with chronic myeloid leukemia
14. Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV
15. Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV
16. The Change in Continuity: Nuer Refugees and Substituted Cattle
17. 9.1 Die interkulturelle Öffnung im deutschen Gesundheitssystem: Ein kritischer Überblick
18. 13.6 Best Practices: Interkulturelle Öffnung im Gesundheitswesen
19. EINFÜHRUNG
20. Deutschland ein Einwanderungsland? Die interkulturelle Öffnung der Bremer Krankenhäuser als kritischer Testfall
21. Lifting the Curse of Isaiah: Pathways of incorporation of transnational Nuer Christians in the homeland and the US
22. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
23. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
24. Diversity im Kontext gesundheitlicher Vulnerabilität: Ethnografische Gesundheitsforschung im Stadtteillabor Bochum
25. Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA
26. Major Route Additional Chromosomal Aberrations (ACA) Precede Increase of Blasts in CML: An Analysis of the German CML-Studies III and IIIA
27. Migration und Gesundheit: Deutschland, Kanada und Italien im Vergleich
28. Defining Therapy Goals for Major Molecular Remission in Chronic Myeloid Leukemia: Results of the Randomized CML-Study IV
29. Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in the Imatinib-Era: Update on the Survival Outcome Following Allogeneic HSCT after Imatinib Failure; Results of the German CML Study IV
30. A Two-Fold Rise of BCR-ABL Transcript Levels Advises BCR-ABL Mutation Analysis in Imatinib-Treated Chronic Myeloid Leukemia (CML) - an Analysis of the Randomized CML-Study IV
31. Comparing the Prognostic Significance of Early Predictors of Survival in Chronic Myeloid Leukemia (CML) Treated with Imatinib - an Analysis of the Randomized CML-Study IV
32. Christian Conversion in a Changing World: Confronting Issues of Inequality, Modernity and Morality
33. Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV
34. Prognostic Factors Identified Via a Cox Proportional Hazard Cure Model Explain Survival Differences After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leukemia (CML) Between Two Consecutive Patient Cohorts
35. Comorbidity, Measured By The Charlson Index, Has No Negative Impact On Remission In Patients With Chronic Myeloid Leukemia: Results Of The Randomized CML-Study IV
36. Adverse Events (AE) Under Imatinib Treatment Over 10 Years: Results From 1501 Patients Of The Randomized CML-Study IV
37. The Cytogenetic Profile In Lymphoid and Myeloid CML Blast Crisis
38. Achievement Of a MR5.0 Within the Randomized CML-Study IV: Feasibility, Differences Between Treatment Arms, and Prognostic Implications
39. Optimizing Early Prediction Of Outcome In CML Using The Exact Decline Of BCR-ABL Transcript Levels Within 3 Months Of Imatinib Treatment As a Prognostic Marker
40. The Impact Of Balanced and Unbalanced Karyotypes On Prognosis Of CML: From Chronic Phase To Blast Crisis
41. Absolute BCR-ABL Transcript Levels At 3 Months but Not At Diagnosis Predict Survival of Chronic Myeloid Leukemia (CML) Patients On Imatinib Therapy
42. Secondary Malignancies in CML Patients – Data From the German CML Study IV
43. Complete Molecular Remission (CMR 4.5) of CML Is Induced Faster by Dose – Optimized Imatinib and Predicts Better Survival - Results From the Randomized CML-Study IV
44. Impact of Balanced or Unbalanced Karyotype At Diagnosis On Prognosis of CML: Long-Term Observation From 1346 Patients of the Randomized CML Study IV
45. Impact of Additional Cytogenetic Alterations At Diagnosis on Prognosis of CML: Long-Term Observation From 1151 Patients of the Randomized CML Study IV
46. Therapy with Imatinib In Elderly CML Patients (>65years): Results of the German CML-Study IV.
47. Drug treatment is superior to allografting as first-line therapy in chronic myeloid leukemia
48. Distinct Characteristics of e13a2 versus e14a2 BCR-ABL Chronic Myeloid Leukemia under Upfront Treatment with Imatinib – an Analysis of the German CML Study IV,
49. Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV,
50. Time-Related Interpretation of Molecular Response Levels According to Long Term Overall and Progression-Free Survival of CML Patients on First-Line Imatinib Treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.